
    
      This is a randomized, single-center, open-label, non- inferiority study designed to evaluate
      the safety, efficacy and potential benefits of Tubeless NOSES compared with traditional
      laparoscopic radical resection in approximately 458 subjects with Rectosigmoid Cancers.
    
  